Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InterMune stock plunges 80% as FDA rejects lung drug

By Hibah Yousuf, staff reporter


NEW YORK (CNNMoney.com) -- Shares of InterMune Inc. plunged nearly 80% after-hours Tuesday following the Food and Drug Administration's rejection of the biotech company's application for Esbriet, a drug designed to treat a fatal lung disease.

The company said the FDA has requested an additional clinical trial to support the effectiveness of Esbriet in patients suffering from idiopathic pulmonary fibrosis, which hinders the body's ability to process oxygen due to inflammation and scarring in the lungs.

"We will meet with the FDA as soon as possible to understand their points of view and to determine the most appropriate path forward to expeditiously make Esbriet available to the approximately 100,000 patients with IPF and their families who suffer from this terrible disease and for whom no FDA-approved medicines exist," InterMune (ITMN) chairman and chief executive Dan Welch said in a prepared statement.

Welch said he was "disappointed" by the outcome, since the FDA's advisory committee recommended the approval of the drug by a 9-3 margin in March.  To top of page

Index Last Change % Change
Dow 17,699.10 47.84 0.27%
Nasdaq 4,730.03 4.39 0.09%
S&P 500 2,054.85 3.73 0.18%
Treasuries 1.79 0.01 0.39%
Data as of 10:48am ET
Company Price Change % Change
Bank of America Corp... 14.19 0.06 0.43%
Chesapeake Energy Co... 5.96 0.31 5.49%
Freeport-McMoRan Inc... 11.87 0.07 0.59%
Apple Inc 92.94 -0.68 -0.72%
Twenty-First Century... 29.90 0.09 0.32%
Data as of 10:33am ET
Sponsors

Sections

Hedge fund billionaire Stanley Druckenmiller warned on Wednesday at the Sohn Investment Conference a debt-fueled disaster is coming in the U.S. and China. More

Hedge fund billionaire Stanley Druckenmiller warned on Wednesday at the Sohn Investment Conference a debt-fueled disaster is coming in the U.S. and China. More

Oakland-based tech startup Clef hosts dinners for the local community in a bid to resist gentrification and unite all types of industries that make up the city. More

Visa says new software will allow consumers to check out with chip cards as fast as swiping a card with magnetic strip. More